Results 81 to 90 of about 21,939 (156)
Case Report: Heterotopic Pancreatic Tissue Leading to Acute on Chronic Cholecystitis. [PDF]
Tekin YB +4 more
europepmc +1 more source
The Evolution of Medications for Obesity Management
ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley +1 more source
Retracted: Effectiveness of Laparoscopic Cholecystectomy in Patients with Gallbladder Stones with Chronic Cholecystitis. [PDF]
And Alternative Medicine EC.
europepmc +1 more source
ABSTRACT Background The American and European Societies of Gastrointestinal Endoscopy (ASGE and ESGE) have published diagnostic guidelines for the evaluation of choledocholithiasis. The applicability and feasibility of these guidelines in a publicly funded health care system, such as ours in Aotearoa New Zealand, are not known. This retrospective study
Henry C. K. Kwok +3 more
wiley +1 more source
Sonographic Assessment of Acute Versus Chronic Cholecystitis: An Ultrasound Probability Stratification Model. [PDF]
Navarro SM +5 more
europepmc +1 more source
Multicenter retrospective analysis of 255 patients undergoing endoscopic papillectomy demonstrated significantly lower rates of delayed bleeding and post‐EP pancreatitis in patients aged ≥ 75 years. Age ≥ 75 75 years was independently associated with reduced risks of both adverse events, while serious complications, complete resection, and recurrence ...
Noriki Kasuga +12 more
wiley +1 more source
Landscape in the gallbladder mycobiome and bacteriome of patients undergoing cholelithiasis with chronic cholecystitis. [PDF]
Hu J +8 more
europepmc +1 more source
ABSTRACT Aims Orforglipron is a novel small‐molecule, once daily oral non‐peptide GLP‐1 receptor agonist. The hepatic safety profile in adults with obesity or overweight and/or type 2 diabetes (T2D) across seven orforglipron Phase 3 clinical trials was assessed.
Sean Wharton +5 more
wiley +1 more source
Chronic cholecystitis from Raoultella planticola infection associated with adenomyomatous hyperplasia. [PDF]
Doherty G, Kreinces J, Souza F, Kim DE.
europepmc +1 more source
ABSTRACT Aims The management of the disease of obesity has been transformed by incretin‐based therapies; however, additional and alternative therapeutic strategies are needed to address its biological complexity. This narrative review examines the physiology of amylin and the emerging role of amylin‐based therapies in obesity management.
Abdulhameed Alhazmi, Carel W. le Roux
wiley +1 more source

